Wockhardt surges 10% on signing Covid-19 deal with UK government
New Delhi: Shares of Wockhardt surged 10 per cent in Tuesday’s trade after the biotechnology major said it has entered into an agreement with the UK government to fill-finish Covid-19 vaccines. The manufacturing will be undertaken at CP Pharmaceuticals, a subsidiary of Wockhardt based in Wrexham, North Wales, the drugmaker said in a BSE filing. … Read more